Synthesis and characterization of hydrogen peroxide activated estrogen receptor beta ligands

Bioorg Med Chem. 2019 May 15;27(10):2075-2082. doi: 10.1016/j.bmc.2019.04.003. Epub 2019 Apr 3.

Abstract

The development and evaluation of selective estrogen receptor modulators (SERMs) is of interest because of the complex and significant role of estrogen receptors in normal tissues as well as disease states. In neurodegenerative disorders such as Alzheimer's disease and multiple sclerosis, estrogen receptor beta (ERβ) seems to provide a protective anti-inflammatory response. Due to the increase in reactive oxygen species (ROS) in these diseases, we have masked ERβ ligands, including diarylpropionitrile (DPN), as boronate esters that release the active estrogen in the presence of H2O2. Here we demonstrate their synthesis, decreased binding affinities, kinetics of release, and selectivity toward ROS. The most promising ligand can be unmasked in the presence of pathological H2O2 to modulate ERβ transcription in cells.

Keywords: Boronic acid pinacol ester; Estrogen; Estrogen receptor beta; Hydrogen peroxide; Pro-drug.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Boronic Acids / chemistry
  • Drug Design
  • Estrogen Receptor beta / chemistry
  • Estrogen Receptor beta / genetics
  • Estrogen Receptor beta / metabolism*
  • Humans
  • Hydrogen Peroxide / metabolism*
  • Hydrogen Peroxide / pharmacology
  • Ligands*
  • Nitriles / chemistry
  • Nitriles / metabolism
  • Nitriles / pharmacology
  • Prodrugs / chemistry
  • Prodrugs / metabolism
  • Prodrugs / pharmacology
  • Propionates / chemistry
  • Propionates / metabolism
  • Propionates / pharmacology
  • Protein Binding
  • Reactive Oxygen Species / metabolism
  • Transcriptional Activation / drug effects

Substances

  • 2,3-bis(4-hydroxyphenyl)-propionitrile
  • Boronic Acids
  • Estrogen Receptor beta
  • Ligands
  • Nitriles
  • Prodrugs
  • Propionates
  • Reactive Oxygen Species
  • Hydrogen Peroxide